Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Rapid-acting insulin formulation comprising a substituted anionic compound

Rapid-acting insulin formulation comprising a substituted anionic compound

US Patent 10881716 · Granted Jan 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydrogels for cell therapy2025
Rapid-acting insulin formulation comprising a substituted anionic compound2022
Rapid-acting insulin formulation comprising a substituted anionic compound2022
Rapid-acting insulin composition comprising a substituted citrate2020
Rapid-acting insulin formulation comprising a substituted anionic compound2020
Rapid-acting insulin formulation comprising a substituted anionic compound2020
Rapid-acting insulin formulation comprising a substituted anionic compound2020
Oral medicinal product with modified release of at least one active principle in2018
Fast-acting insulin composition comprising a substituted anionic compound and a 2017
Rapid-acting insulin formulation comprising a substituted anionic compound2017
Rapid-acting insulin formulation comprising an oligosaccharide2016
Injectable solution at pH 7 comprising at least one basal insulin whose PI is be2015